Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
09 January 2026New antimicrobial substances to combat increasing resistance
Antimicrobial resistance (AMR) represents a major and escalating global health threat, with an estimated 4.71 million deaths associated with AMR in 2021 and 1.14 million directly attributable to infections caused by multidrug-resistant organisms, particularly multidrug-resistant Gram-negative bacteria such as resistant Enterobacterales, Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii, which the World Health Organization identifies as priority […]
Read more... -
08 January 2026Rethinking the unmet need for novel antibiotics
The authors argue that the fundamental challenge in antibiotic development is not only addressing deaths from specific highly resistant pathogens, but more critically overcoming high rates of empiric treatment failure that clinicians face when first treating infections. They propose reframing the problem to focus on developing pathogen-general potentiators—agents that improve the success of empiric therapy […]
Read more... -
07 January 2026Artificial intelligence for sustainable solutions in combating antimicrobial resistance through data driven health innovations
Artificial intelligence is emerging as a transformative tool in combating antimicrobial resistance by supporting drug discovery, diagnostics, and surveillance. AI-driven resources enable the identification of compounds that disrupt microbial biofilms, improve detection of AMR markers from genomic and metagenomic data, and enhance monitoring systems. Advanced machine-learning and deep-learning approaches accelerate antibiotic development by predicting bacterial […]
Read more...
More news related to Smart innovation
